{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:52:03Z","timestamp":1768834323870,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010486","name":"Teijin Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016170","name":"Japan Blood Products Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jiac.2015.01.012","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T20:36:18Z","timestamp":1424291778000},"page":"427-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus"],"prefix":"10.1016","volume":"21","author":[{"given":"Misako","family":"Yajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Daikoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3686-783X","authenticated-orcid":false,"given":"Kimiyasu","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2015.01.012_bib1","first-page":"466","article-title":"Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus","volume":"18","author":"Negishi","year":"1998","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.jiac.2015.01.012_bib2","doi-asserted-by":"crossref","first-page":"S392","DOI":"10.1093\/clinids\/17.Supplement_2.S392","article-title":"Prevention and treatment of cytomegalovirus pneumonia in transplant recipients","volume":"17","author":"Zaia","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.01.012_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1034\/j.1399-3062.2001.00002.x","article-title":"Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation","volume":"3","author":"Snydman","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jiac.2015.01.012_bib4","doi-asserted-by":"crossref","first-page":"S839","DOI":"10.1093\/clinids\/12.Supplement_7.S839","article-title":"Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease","volume":"12","author":"Snydman","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jiac.2015.01.012_bib5","first-page":"144","article-title":"S-sulfonation: a reversible chemical modification of human immunoglobulins permitting intravenous application. I. Physicochemical and binding properties of s-sulfonated and reconstituted IgG","volume":"45","author":"Gronski","year":"1983","journal-title":"Vox Sang"},{"key":"10.1016\/j.jiac.2015.01.012_bib6","first-page":"290","article-title":"Development of an intravenous gamma-globulin with fc activities. II. Reconversion of s-sulfonated human gamma-globulin into the original gamma-globulin","volume":"32","author":"Masuho","year":"1977","journal-title":"Vox Sang"},{"key":"10.1016\/j.jiac.2015.01.012_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0167-4781(97)00120-6","article-title":"Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mrna","volume":"1354","author":"Matsumoto","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jiac.2015.01.012_bib8","first-page":"155","article-title":"S-sulfonation: a reversible chemical modification of human immunoglobulins permitting intravenous application. II. Effect on fc-mediated effector functions","volume":"45","author":"Hofstaetter","year":"1983","journal-title":"Vox Sang"},{"key":"10.1016\/j.jiac.2015.01.012_bib9","first-page":"175","article-title":"Development of an intravenous gamma-globulin with fc activities. I. Preparation and characterization of s-sulfonated human gamma-globulin","volume":"32","author":"Masuho","year":"1977","journal-title":"Vox Sang"},{"key":"10.1016\/j.jiac.2015.01.012_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00441918","article-title":"Clinical trial of sulfonated immunoglobulin preparation for intravenous administration. I. Replacement therapy for primary immunodeficiency syndromes","volume":"136","author":"Kobayashi","year":"1981","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jiac.2015.01.012_bib11","first-page":"25","article-title":"Development of a live attenuated varicella vaccine","volume":"18","author":"Takahashi","year":"1975","journal-title":"Biken J"},{"key":"10.1016\/j.jiac.2015.01.012_bib12","doi-asserted-by":"crossref","unstructured":"Shiraki K, Daikoku T, Takemoto M, Yoshida Y, Suzuki K, Akahori Y, et\u00a0al. Neutralizing anti-gH antibody of varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency. J Virol 85:8172\u201380.","DOI":"10.1128\/JVI.00435-11"},{"key":"10.1016\/j.jiac.2015.01.012_bib13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/0022-1317-72-6-1393","article-title":"Development of immunogenic recombinant OKA varicella vaccine expressing hepatitis b virus surface antigen","volume":"72","author":"Shiraki","year":"1991","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jiac.2015.01.012_bib14","first-page":"15","article-title":"Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster","volume":"21","author":"Asano","year":"1978","journal-title":"Biken J"},{"key":"10.1016\/j.jiac.2015.01.012_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01310762","article-title":"Immunosuppressive dose of azathioprine inhibits replication of human cytomegalovirus in\u00a0vitro","volume":"117","author":"Shiraki","year":"1991","journal-title":"Arch Virol"},{"key":"10.1016\/j.jiac.2015.01.012_bib16","doi-asserted-by":"crossref","unstructured":"Kuramoto T, Daikoku T, Yoshida Y, Takemoto M, Oshima K, Eizuru Y, et\u00a0al. Novel anticytomegalovirus activity of immunosuppressant mizoribine and its synergism with ganciclovir. J Pharmacol Exp Ther 333:816\u201321.","DOI":"10.1124\/jpet.109.160630"},{"key":"10.1016\/j.jiac.2015.01.012_bib17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/jmv.20838","article-title":"Isolation of therapeutic human monoclonal antibodies for varicella-zoster virus and the effect of light chains on the neutralizing activity","volume":"79","author":"Suzuki","year":"2007","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jiac.2015.01.012_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1099\/0022-1317-61-2-255","article-title":"Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV)","volume":"61","author":"Shiraki","year":"1982","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jiac.2015.01.012_bib19","first-page":"179","article-title":"Human lymphocyte, monocyte and polymorphonuclear leucocyte mediated antibody-dependent cellular cytotoxicity against varicella-zoster virus-infected targets","volume":"63","author":"Ihara","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jiac.2015.01.012_bib20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/oxfordjournals.jbchem.a131799","article-title":"Interaction of s-sulfonated human IgG with human complement and its components","volume":"82","author":"Fukumoto","year":"1977","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.jiac.2015.01.012_bib21","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.4049\/jimmunol.114.6.1726","article-title":"The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin g and complement","volume":"114","author":"Isenman","year":"1975","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jiac.2015.01.012_bib22","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.4049\/jimmunol.164.10.5313","article-title":"The IgG Fc contains distinct fc receptor (FcR) binding sites: the leukocyte receptors fc gamma RI and Fc gamma RIIa bind to a region in the fc distinct from that recognized by neonatal FcR and protein A","volume":"164","author":"Wines","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jiac.2015.01.012_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/35018508","article-title":"The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex","volume":"406","author":"Sondermann","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jiac.2015.01.012_bib24","doi-asserted-by":"crossref","first-page":"16469","DOI":"10.1074\/jbc.M100350200","article-title":"The structure of a human type Iii Fcgamma receptor in complex with Fc","volume":"276","author":"Radaev","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jiac.2015.01.012_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/jvi.51.1.110-116.1984","article-title":"Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts","volume":"51","author":"Ihara","year":"1984","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jiac.2015.01.012_bib26","first-page":"215","article-title":"Augmentation of natural killer cell activity induced by cytomegalovirus infection in mice treated with FK506","volume":"41","author":"Kageyama","year":"1997","journal-title":"Acta Virol"},{"key":"10.1016\/j.jiac.2015.01.012_bib27","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe herpesvirus infections in an adolescent without natural killer cells","volume":"320","author":"Biron","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2015.01.012_bib28","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1073\/pnas.78.8.5104","article-title":"Increased susceptibility to cytomegalovirus infection in beige mutant mice","volume":"78","author":"Shellam","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jiac.2015.01.012_bib29","doi-asserted-by":"crossref","unstructured":"Noriega V, Redmann V, Gardner T, Tortorella D. Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 54:140\u201351.","DOI":"10.1007\/s12026-012-8304-8"},{"key":"10.1016\/j.jiac.2015.01.012_bib30","first-page":"333","article-title":"Cytomegalovirus immune evasion","volume":"325","author":"Powers","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jiac.2015.01.012_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/CMR.00034-08","article-title":"Immunobiology of human cytomegalovirus: from bench to bedside","volume":"22","author":"Crough","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2015.01.012_bib32","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1128\/JVI.76.17.8596-8608.2002","article-title":"Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs","volume":"76","author":"Atalay","year":"2002","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jiac.2015.01.012_bib33","doi-asserted-by":"crossref","first-page":"11218","DOI":"10.1128\/JVI.75.22.11218-11221.2001","article-title":"Human cytomegalovirus open reading frame TRL11\/IRL11 encodes an immunoglobulin G Fc-binding protein","volume":"75","author":"Lilley","year":"2001","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jiac.2015.01.012_bib34","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1128\/JVI.01476-07","article-title":"The human cytomegalovirus fc receptor gp68 binds the Fc CH2\u2013CH3 interface of immunoglobulin g","volume":"82","author":"Sprague","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jiac.2015.01.012_bib35","doi-asserted-by":"crossref","unstructured":"Corrales-Aguilar E, Trilling M, Hunold K, Fiedler M, Le VT, Reinhard H, et\u00a0al. Human cytomegalovirus fcgamma binding proteins gp34 and gp68 antagonize fcgamma receptors I, II and III. PLoS Pathog 10:e1004131.","DOI":"10.1371\/journal.ppat.1004131"},{"key":"10.1016\/j.jiac.2015.01.012_bib36","doi-asserted-by":"crossref","unstructured":"Couzi L, Pitard V, Sicard X, Garrigue I, Hawchar O, Merville P, et\u00a0al. Antibody-dependent anti-cytomegalovirus activity of human gammadelta t cells expressing cd16 (FcgammaRIIIa). Blood, 119:1418\u201327.","DOI":"10.1182\/blood-2011-06-363655"},{"key":"10.1016\/j.jiac.2015.01.012_bib37","series-title":"Characteristics of s-sulfonated gammaglobulin and its restored form","author":"Tomibe","year":"1978"},{"key":"10.1016\/j.jiac.2015.01.012_bib38","series-title":"Immunology: understanding the immune system","author":"Elgert","year":"1998"},{"key":"10.1016\/j.jiac.2015.01.012_bib39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncprheum0481","article-title":"Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action","volume":"3","author":"Bayry","year":"2007","journal-title":"Nat Clin Pract Rheumatol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X15000318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X15000318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:53:36Z","timestamp":1761159216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X15000318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1341321X15000318"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2015.01.012","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2015.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}